You are here

Sarepta drug protects lab monkeys from Ebola

Primary tabs

REUTERS   by Sharon Begley                                                                                      Feb. 10, 2015

NEW YORK --An experimental Ebola drug from Sarepta Therapeutics Inc protected six of eight lab monkeys injected with the virus, scientists from the company and the U.S. Army reported on Tuesday.

The drug, called AVI-7537, joins ZMapp from Mapp Biopharmaceutical and a compound from Tekmira Pharmaceuticals Corp as the agents shown to cure non-human primates given otherwise-lethal injections of Ebola virus.

The ZMapp and Tekmira drugs protected 100 percent of lab monkeys in studies, giving them a possible edge. But, unlike those, Sarepta's drug has been formally tested in healthy human volunteers at high doses and caused no serious side effects.

Sarepta's $300 million contract with the U.S. Department of Defense to develop drugs against Ebola and the related Marburg virus ended in 2012 due to government funding cuts. The study was completed just before then but not published until the current Ebola outbreak increased interest in the drug....

Read complete story.
http://news.yahoo.com/sarepta-drug-protects-lab-monkeys-ebola-143146851--finance.html;_ylt=AwrBEiJBidtU5yAAhHLQtDMD

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
howdy folks